Skip to content
Atlas of Computational Cell Reprogramming
L2 · Proxy inverse design

Inverse design fidelity

Level 2 · Proxy inverse design

Uses an empirical or learned proxy response map (signature reversal, latent displacement, drug-response prediction, or network propagation) rather than a mechanistic model.

The level's compact mathematical form.

Methods at this level

10 methods

Sorted by publication year, oldest first.

Alvarez et al. · 2018 · Cancer Discovery

Classical Level 2 proxy method. Estimates master-regulator activity with VIPER and ranks compounds by their ability to reverse that activity profile against perturbation atlases.

P
Code Repro 3/4 FAIR 3/5

Marazzi L et al. · 2020 · Bioinformatics (Oxford, England)

SUMMARY: OCSANA+ is a Cytoscape app for identifying nodes to drive the system toward a desired long-term behavior, prioritizing combinations of interventions in large-scale complex networks, and estimating the effects…

D P
Code Repro 4/4 FAIR 2/5

Napolitano F et al. · 2021 · Stem cell reports

Controlling cell fate has great potential for regenerative medicine, drug discovery, and basic research.

I
Code Repro 2/4 FAIR 3/5

Tran A et al. · 2022 · NAR genomics and bioinformatics

Cell reprogramming offers a potential treatment to many diseases, by regenerating specialized somatic cells.

D
Code Repro 2/4 FAIR 0/5

Han L et al. · 2023 · Communications biology

Cellular transitions hold great promise in translational medicine research.

I D T
No code

Zheng M et al. · 2023 · Stem cell reports

Cellular conversion can be induced by perturbing a handful of key transcription factors (TFs).

I D T P
Code Repro 4/4 FAIR 1/5

Hamano M et al. · 2024 · Bioinformatics (Oxford, England)

MOTIVATION: Direct reprogramming (DR) is a process that directly converts somatic cells to target cells.

T
Code Repro 2/4 FAIR 0/5

Wytock TP et al. · 2024 · Proceedings of the National Academy of Sciences of the United States of America

Recent developments in synthetic biology, next-generation sequencing, and machine learning provide an unprecedented opportunity to rationally design new disease treatments based on measured responses to gene…

I T P
Code Repro 4/4 FAIR 1/5

DeMeo B et al. · 2025 · Science (New York, N.Y.)

Phenotypic drug screening remains constrained by the vastness of chemical space and the technical challenges of scaling experimental workflows.

D P
Code Repro 4/4 FAIR 3/5

Jung S et al. · 2025 · Aging

Great efforts have been devoted to discovering rejuvenation strategies that counteract age-related functional decline and improve cellular functions in humans.

P
Code Repro 2/4 FAIR 1/5

Other levels